Fan Zhang, Ph.D.
Assistant Professor
On This Page
About Fan Zhang
Lab website: https://zhang.pharmacy.ufl.edu/
Fan Zhang, Ph.D. received his Ph.D. from Johns Hopkins University in Materials Science & Engineering. His graduate work established the guiding principles for designing nanomedicines to target neuroinflammation. To expand the clinical impact of his research, he then undertook postdoctoral training at the clinical research division of Fred Hutchinson Cancer Research Center. This experience solidified his foundation in immuno-oncology, cell & gene therapy, and experimental tumor models. His work has led to the development of a polymer-based platform that genetically programs immune cells for cancer treatment, which is under clinical translation. His work has led to four patents and contributed to the foundation of two start-up companies. His current research focuses on harnessing myeloid cell recruitment for enhanced drug delivery. To this end, his research program leverages materials science, cell engineering, and immunology to determine the fundamental principles that govern nanoparticle’s interaction with immune cells and their tissue tropism, and to elucidate how immune cell recruitment affects nanotherapeutic in vivo targeting behaviors.
Accomplishments
Teaching Profile
Courses Taught
Research Profile
Dr.Zhang’s research focuses on developing synthetic nanoplatforms to direct immune cells as ‘living therapeutics’. To this end, his laboratory integrates materials science, immunology, synthetic biology, and translational medicine to create novel nanotherapeutics for controlled modulation of the immune system. The overarching goal of his research is to establish a fundamental understanding of nanotherapeutic design and the ways it interacts with the immune system. The ultimate goal of his research is to translate nanomedicine to the clinic. Dr.Zhang’s laboratory seeks to create a unique working environment by fostering interdisciplinary and translational collaboration. The current research focuses include: (1) engineering synthetic nanoplatforms; (2) engineering synthetic cell-based therapy; (3) physiology-guided drug delivery.
0000-0002-2491-3600
Areas of Interest
- CNS Cancer
- Cell and Gene Therapy
- Drug delivery
- Immuno-Oncology
- Immunotherapy
- Nanomedicine
- Neuroinflammation
Publications
Academic Articles
Grants
-
Development of a web-based predictive model of nanoparticle delivery to tumors by integrating physiologically-based pharmacokinetic modeling with artificial intelligence
Active
- Role:
- Co-Investigator
- Funding:
- NATL INST OF HLTH NIBIB
-
Reveal myeloid cell-mediated targeting through nano-bio interface
Active
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NIGMS
-
Institutional Career Development Core
- Role:
- Project Manager
- Funding:
- NATL INST OF HLTH NCATS
-
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
Active
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NCI
-
Selectively targeting macrophage subsets with dendrimer-based STING Agonist Prodrug
- Role:
- Principal Investigator
- Funding:
- AMER BRAIN TUMOR ASSOCIATION
-
In situ program CAR-Macrophage against glioblastoma
- Role:
- Principal Investigator
- Funding:
- OCALA ROYAL DAMES FOR CANCER RESEARCH
-
American Cancer Society Institutional Research Grant
Active
- Role:
- Project Manager
- Funding:
- AMERICAN CANCER SOCIETY
-
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology
Active
- Role:
- Project Manager
- Funding:
- NATL INST OF HLTH NIGMS
Education
-
Postdoc, Program in Immunology
Fred Hutchinson Cancer Research Center, Seattle, USA
-
Ph.D., Materials Science and Engineering
Johns Hopkins University, Baltimore, USA
-
B.S., Materials Science and Engineering
Donghua University, Shanghai, China
Contact Details
- Business:
- (352) 294-8287
- Business:
- fzhang1@ufl.edu
- Business Mailing:
-
PO Box 100494
GAINESVILLE FL 32610 - Business Street:
-
Medical Science Building, P3-20C
1345 Center Dr.
Gainesville FL 32610